Berkeley Lights CEO Siddhartha Kadia (L) and IsoPlexis CEO Sean Mackay
December 22, 2022 08:18 AM EST
Deals

Berke­ley Lights to ac­quire Iso­Plex­is in $57.8M all-stock deal

Katherine Lewin

News Reporter

Bi­ol­o­gy tools com­pa­ny Berke­ley Lights will ac­quire Iso­Plex­is in a $57.8 mil­lion all-stock trans­ac­tion agree­ment an­nounced Wednes­day. The new com­pa­ny will be named

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times